PRESS RELEASE published on 09/26/2025 at 08:00, 2 months 26 days ago Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acute Myeloid Leukemia Trial Pentixapharm advances PentixaTher to fourth dose level in AML trial, reinforcing safety profile and potential clinical efficacy for CXCR4-targeted radiotherapeutic in high unmet need indication Pentixapharm CXCR4 Acute Myeloid Leukemia Radiotherapeutic PentixaTher
PRESS RELEASE published on 09/26/2025 at 08:00, 2 months 26 days ago Restart of Kurdistan crude exports via the Iraq-Türkiye Pipeline Gulf Keystone Petroleum Ltd announces the restart of Kurdistan crude exports via the Iraq-Türkiye Pipeline, in compliance with Iraq's Budget Law. Expectations for improved realized prices and long-term investments in oil and gas reserves Kurdistan Gulf Keystone Petroleum Oil Exports Iraq-Türkiye Pipeline Production Sharing Contracts
PRESS RELEASE published on 09/26/2025 at 08:00, 2 months 26 days ago Pyrum Innovations AG publishes figures for the first half of 2025 Pyrum Innovations AG publishes figures showing revenue increase and improved EBITDA for the first half of 2025. Earnings forecast maintained for the full year despite lower output expectations Revenue Increase EBITDA Earnings Forecast Pyrum Innovations AG Output Expectations
PRESS RELEASE published on 09/26/2025 at 08:00, 2 months 26 days ago Bitcoin Group SE publishes results for the first half year 2025 – focus on redevelopment of crypto trading platform Bitcoin Group SE reports 2025 half-year results with focus on redevelopment of crypto trading platform. Decline in revenue due to market volatility. Emphasis on new trading platform development Revenue Decline Half-year Results Bitcoin Group SE Crypto Trading Platform New Trading Platform
REGULATED PRESS RELEASE published on 09/26/2025 at 07:30, 2 months 26 days ago Gimv and EGS Beteiligungen reinforce strategic support for Spineart with CHF 25 million capital increase to accelerate global growth Spineart secures CHF 25 million investment from Gimv and EGS Beteiligungen to accelerate global expansion in advanced spine surgery solutions Gimv Investment Spine Surgery EGS Beteiligungen Spineart
REGULATED PRESS RELEASE published on 09/26/2025 at 07:30, 2 months 26 days ago Gimv en EGS Beteiligungen versterken hun strategische steun aan Spineart met kapitaalverhoging van 25 miljoen CHF ter versnelling van wereldwijde groei Gimv en EGSB versterken strategische steun aan Spineart met kapitaalverhoging van 25 miljoen CHF voor wereldwijde groei in wervelkolomchirurgie Gimv Kapitaalverhoging Spineart EGSB Wervelkolomchirurgie
REGULATED PRESS RELEASE published on 09/26/2025 at 07:30, 2 months 26 days ago Gimv and EGS Beteiligungen reinforce strategic support for Spineart with CHF 25 million capital increase to accelerate global growth Gimv and EGS Beteiligungen invest CHF 25 million in Spineart to boost global growth in advanced spine surgery solutions Gimv Global Growth EGS Beteiligungen Spineart CHF 25 Million
PRESS RELEASE published on 09/26/2025 at 07:30, 2 months 26 days ago Informations privilégiées / Autres communiqués Hoffmann Green annonce le vif succès de son augmentation de capital d'environ 7,9 M€ pour accélérer son développement commercial et industriel Augmentation De Capital Décarbonation Développement Commercial Succès Hoffmann Green
PRESS RELEASE published on 09/26/2025 at 07:30, 2 months 26 days ago Inside Information / Other news releases Hoffmann Green Cement announces successful €7.9 million capital increase for commercial and industrial growth. New shares issued at €4.50 unit price. Settlement on September 30, 2025 Capital Increase New Shares Commercial Development Hoffmann Green Cement Industrial Growth
PRESS RELEASE published on 09/26/2025 at 07:00, 2 months 26 days ago OSE Immunotherapeutics, Inserm Transfert et Nantes Université annoncent un partenariat stratégique pour accélérer l’innovation en immunothérapie Partenariat stratégique entre OSE Immunotherapeutics, Inserm Transfert et Nantes Université pour accélérer l'innovation en immunothérapie. Objectif : transformer découvertes académiques en thérapies de rupture Partenariat Immunothérapie OSE Immunotherapeutics Inserm Transfert Nantes Université
Published on 12/22/2025 at 23:35, 1 hour 14 minutes ago Cypher Metaverse Inc. Announces Closing of Financing
Published on 12/22/2025 at 23:05, 1 hour 44 minutes ago BlackBerry to Host Investor Briefing at CES 2026
Published on 12/22/2025 at 22:50, 1 hour 59 minutes ago American Critical Minerals Clarifies Technical Disclosure
Published on 12/22/2025 at 22:35, 2 hours 14 minutes ago NioCorp to Begin Construction of Mine Portal at Its Elk Creek Critical Minerals Project
Published on 12/22/2025 at 22:02, 2 hours 47 minutes ago Unusual Machines Receives Initial Order from Performance Drone Works for $3.75 Million as Part of a Strategic Supplier Relationship
Published on 12/23/2025 at 00:15, 33 minutes ago FINALS, SEMI-FINALS AND NON-STOP ACTION AS GOTF 2025 REACHES CLIMAX
Published on 12/22/2025 at 22:05, 2 hours 43 minutes ago mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
Published on 12/22/2025 at 21:36, 3 hours 12 minutes ago Revolution Wind and Sunrise Wind receive lease suspension orders from US Department of the Interior’s Bureau of Ocean Energy Management
Published on 12/22/2025 at 20:16, 4 hours 32 minutes ago EQS-Adhoc: PIERER Mobility AG (to be renamed soon to Bajaj Mobility AG): CEO Gottfried Neumeister confirmed until the end of 2028
Published on 12/22/2025 at 18:33, 6 hours 16 minutes ago ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 6 hours 44 minutes ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 6 hours 44 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 7 hours 4 minutes ago Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 7 hours 14 minutes ago DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025